SVB Leerink initiated coverage on VectivBio Holding with a new price target
$VECT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
SVB Leerink initiated coverage of VectivBio Holding with a rating of Outperform and set a new price target of $28.00